{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T15:53:13Z","timestamp":1793029993952,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LQ21H160030"],"award-info":[{"award-number":["LQ21H160030"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81972374"],"award-info":[{"award-number":["81972374"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-025-00724-x","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T13:05:30Z","timestamp":1740402330000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Proteome-wide Mendelian randomization identifies causal plasma proteins in prostate cancer development"],"prefix":"10.1186","volume":"19","author":[{"given":"Jian","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zitong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiafeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sida","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8008-8724","authenticated-orcid":false,"given":"Xiangyi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"issue":"2","key":"724_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"P Rawla","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63\u201389.","journal-title":"World J Oncol"},{"issue":"6","key":"724_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 24","key":"724_CR3","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1002\/cncr.31026","volume":"123 Suppl 24","author":"CB Steele","year":"2017","unstructured":"Steele CB, Li J, Huang B, Weir HK. Prostate cancer survival in the United States by race and stage (2001\u20132009): Findings from the CONCORD-2 study. Cancer. 2017;123 Suppl 24(Suppl 24):5160\u201377.","journal-title":"Cancer"},{"issue":"1","key":"724_CR4","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1038\/s41467-018-06302-1","volume":"9","author":"N Mancuso","year":"2018","unstructured":"Mancuso N, Gayther S, Gusev A, Zheng W, Penney KL, Kote-Jarai Z, Eeles R, Freedman M, Haiman C, Pasaniuc B, et al. Large-scale transcriptome-wide association study identifies new prostate cancer risk regions. Nat Commun. 2018;9(1):4079.","journal-title":"Nat Commun"},{"issue":"9","key":"724_CR5","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/ijc.33221","volume":"147","author":"X Sun","year":"2020","unstructured":"Sun X, Ye D, Du L, Qian Y, Jiang X, Mao Y. Genetically predicted levels of circulating cytokines and prostate cancer risk: a Mendelian randomization study. Int J Cancer. 2020;147(9):2469\u201378.","journal-title":"Int J Cancer"},{"issue":"7","key":"724_CR6","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/obr.12674","volume":"19","author":"KM Di Sebastiano","year":"2018","unstructured":"Di Sebastiano KM, Pinthus JH, Duivenvoorden WCM, Mourtzakis M. Glucose impairments and insulin resistance in prostate cancer: the role of obesity, nutrition and exercise. Obes Rev. 2018;19(7):1008\u201316.","journal-title":"Obes Rev"},{"key":"724_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/1479-5876-9-162","volume":"9","author":"C Mengus","year":"2011","unstructured":"Mengus C, Le Magnen C, Trella E, Yousef K, Bubendorf L, Provenzano M, Bachmann A, Heberer M, Spagnoli GC, Wyler S. Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer. J Transl Med. 2011;9:162.","journal-title":"J Transl Med"},{"issue":"1","key":"724_CR8","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/s41467-022-29235-2","volume":"13","author":"TZ Minas","year":"2022","unstructured":"Minas TZ, Candia J, Dorsey TH, Baker F, Tang W, Kiely M, Smith CJ, Zhang AL, Jordan SV, Obadi OM, et al. Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer. Nat Commun. 2022;13(1):1759.","journal-title":"Nat Commun"},{"issue":"1","key":"724_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith GD, Ebrahim S. \u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32(1):1\u201322.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"724_CR10","doi-asserted-by":"publisher","first-page":"3268","DOI":"10.1038\/s41467-018-05512-x","volume":"9","author":"C Yao","year":"2018","unstructured":"Yao C, Chen G, Song C, Keefe J, Mendelson M, Huan T, Sun BB, Laser A, Maranville JC, Wu H, et al. Genome-wide mapping of plasma protein QTLs identifies putatively causal genes and pathways for cardiovascular disease. Nat Commun. 2018;9(1):3268.","journal-title":"Nat Commun"},{"issue":"10","key":"724_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41588-020-0682-6","volume":"52","author":"J Zheng","year":"2020","unstructured":"Zheng J, Haberland V, Baird D, Walker V, Haycock PC, Hurle MR, Gutteridge A, Erola P, Liu Y, Luo S, et al. Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases. Nat Genet. 2020;52(10):1122\u201331.","journal-title":"Nat Genet"},{"issue":"1","key":"724_CR12","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","volume":"11","author":"S Shah","year":"2020","unstructured":"Shah S, Henry A, Roselli C, Lin H, Sveinbj\u00f6rnsson G, Fatemifar G, Hedman \u00c5K, Wilk JB, Morley MP, Chaffin MD, et al. Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure. Nat Commun. 2020;11(1):163.","journal-title":"Nat Commun"},{"key":"724_CR13","doi-asserted-by":"crossref","unstructured":"Desai TA, Hedman \u00c5 K, Dimitriou M, Koprulu M, Figiel S, Yin W, Johansson M, Watts EL, Atkins JR, Sokolov AV et al: Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics. medRxiv : the preprint server for health sciences 2023.","DOI":"10.1101\/2023.09.21.23295864"},{"issue":"1","key":"724_CR14","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1186\/s12967-023-04525-5","volume":"21","author":"F Ren","year":"2023","unstructured":"Ren F, Jin Q, Liu T, Ren X, Zhan Y. Proteome-wide mendelian randomization study implicates therapeutic targets in common cancers. J Transl Med. 2023;21(1):646.","journal-title":"J Transl Med"},{"issue":"5","key":"724_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41588-022-01051-w","volume":"54","author":"J Zhang","year":"2022","unstructured":"Zhang J, Dutta D, Kottgen A, Tin A, Schlosser P, Grams ME, Harvey B, Consortium CK, Yu B, Boerwinkle E, et al. Plasma proteome analyses in individuals of European and African ancestry identify cis-pQTLs and models for proteome-wide association studies. Nat Genet. 2022;54(5):593\u2013602.","journal-title":"Nat Genet"},{"issue":"7","key":"724_CR16","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","volume":"50","author":"FR Schumacher","year":"2018","unstructured":"Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 2018;50(7):928\u201336.","journal-title":"Nat Genet"},{"issue":"7944","key":"724_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipila TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"key":"724_CR18","doi-asserted-by":"crossref","unstructured":"The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol. 1989;129(4):687\u2013702.","DOI":"10.1093\/oxfordjournals.aje.a115184"},{"issue":"12","key":"724_CR19","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41591-019-0665-2","volume":"25","author":"SA Williams","year":"2019","unstructured":"Williams SA, Kivimaki M, Langenberg C, Hingorani AD, Casas JP, Bouchard C, Jonasson C, Sarzynski MA, Shipley MJ, Alexander L, et al. Plasma protein patterns as comprehensive indicators of health. Nat Med. 2019;25(12):1851\u20137.","journal-title":"Nat Med"},{"issue":"9","key":"724_CR20","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U Vosa","year":"2021","unstructured":"Vosa U, Claringbould A, Westra HJ, Bonder MJ, Deelen P, Zeng B, Kirsten H, Saha A, Kreuzhuber R, Yazar S, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53(9):1300\u201310.","journal-title":"Nat Genet"},{"issue":"17","key":"724_CR21","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1093\/bioinformatics\/btq340","volume":"26","author":"CJ Willer","year":"2010","unstructured":"Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26(17):2190\u20131.","journal-title":"Bioinformatics"},{"issue":"2","key":"724_CR22","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44(2):512\u201325.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"724_CR23","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"724_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, Plagnol V. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5): e1004383.","journal-title":"PLoS Genet"},{"key":"724_CR25","doi-asserted-by":"publisher","first-page":"e34408","DOI":"10.7554\/eLife.34408","volume":"7","author":"G Hemani","year":"2018","unstructured":"Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408.","journal-title":"Elife"},{"issue":"6","key":"724_CR26","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1093\/ije\/dyx034","volume":"46","author":"OO Yavorska","year":"2017","unstructured":"Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46(6):1734\u20139.","journal-title":"Int J Epidemiol"},{"issue":"3","key":"724_CR27","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.ymthe.2021.01.002","volume":"29","author":"M Abdel Mouti","year":"2021","unstructured":"Abdel Mouti M, Pauklin S. TGFB1\/INHBA homodimer\/nodal-SMAD2\/3 signaling network: a pivotal molecular target in PDAC treatment. Mol Ther. 2021;29(3):920\u201336.","journal-title":"Mol Ther"},{"issue":"6","key":"724_CR28","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1158\/0008-5472.CAN-08-3961","volume":"69","author":"J Yang","year":"2009","unstructured":"Yang J, Wahdan-Alaswad R, Danielpour D. Critical role of Smad2 in tumor suppression and transforming growth factor-beta-induced apoptosis of prostate epithelial cells. Cancer Res. 2009;69(6):2185\u201390.","journal-title":"Cancer Res"},{"issue":"6","key":"724_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cmet.2021.03.009","volume":"33","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhu Z, Yan H, Wang W, Wu Z, Zhang F, Zhang Q, Shi G, Du J, Cai H, et al. Creatine promotes cancer metastasis through activation of Smad2\/3. Cell Metab. 2021;33(6):1111\u201323.","journal-title":"Cell Metab"},{"issue":"8","key":"724_CR30","first-page":"2722","volume":"118","author":"KE Hoot","year":"2008","unstructured":"Hoot KE, Lighthall J, Han G, Lu SL, Li A, Ju W, Kulesz-Martin M, Bottinger E, Wang XJ. Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest. 2008;118(8):2722\u201332.","journal-title":"J Clin Invest"},{"issue":"2","key":"724_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1158\/0008-5472.CAN-12-2706","volume":"73","author":"NI Fleming","year":"2013","unstructured":"Fleming NI, Jorissen RN, Mouradov D, Christie M, Sakthianandeswaren A, Palmieri M, Day F, Li S, Tsui C, Lipton L, et al. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Can Res. 2013;73(2):725\u201335.","journal-title":"Can Res"},{"issue":"9","key":"724_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.333","volume":"4","author":"N Yang","year":"2013","unstructured":"Yang N, Zhao B, Rasul A, Qin H, Li J, Li X. PIAS1-modulated Smad2\/4 complex activation is involved in zinc-induced cancer cell apoptosis. Cell Death Dis. 2013;4(9): e811.","journal-title":"Cell Death Dis"},{"issue":"5","key":"724_CR33","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1093\/jb\/mvr041","volume":"149","author":"R Asada","year":"2011","unstructured":"Asada R, Kanemoto S, Kondo S, Saito A, Imaizumi K. The signalling from endoplasmic reticulum-resident bZIP transcription factors involved in diverse cellular physiology. J Biochem. 2011;149(5):507\u201318.","journal-title":"J Biochem"},{"issue":"3","key":"724_CR34","first-page":"721","volume":"62","author":"H Qi","year":"2002","unstructured":"Qi H, Fillion C, Labrie Y, Grenier J, Fournier A, Berger L, El-Alfy M, Labrie C. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Cancer Res. 2002;62(3):721\u201333.","journal-title":"Cancer Res"},{"issue":"3\u20135","key":"724_CR35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jsbmb.2007.09.008","volume":"108","author":"C Labrie","year":"2008","unstructured":"Labrie C, Lessard J, Ben Aicha S, Savard MP, Pelletier M, Fournier A, Lavergne E, Calvo E. Androgen-regulated transcription factor AIbZIP in prostate cancer. J Steroid Biochem Mol Biol. 2008;108(3\u20135):237\u201344.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"724_CR36","doi-asserted-by":"publisher","first-page":"45300","DOI":"10.1038\/srep45300","volume":"7","author":"TH Kim","year":"2017","unstructured":"Kim TH, Park JM, Kim MY, Ahn YH. The role of CREB3L4 in the proliferation of prostate cancer cells. Sci Rep. 2017;7:45300.","journal-title":"Sci Rep"},{"issue":"12","key":"724_CR37","doi-asserted-by":"publisher","first-page":"10315","DOI":"10.1074\/jbc.M111122200","volume":"277","author":"Y Kishima","year":"2002","unstructured":"Kishima Y, Yamamoto H, Izumoto Y, Yoshida K, Enomoto H, Yamamoto M, Kuroda T, Ito H, Yoshizaki K, Nakamura H. Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals. J Biol Chem. 2002;277(12):10315\u201322.","journal-title":"J Biol Chem"},{"issue":"7","key":"724_CR38","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/cncr.11653","volume":"98","author":"TH Hu","year":"2003","unstructured":"Hu TH, Huang CC, Liu LF, Lin PR, Liu SY, Chang HW, Changchien CS, Lee CM, Chuang JH, Tai MH. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Cancer. 2003;98(7):1444\u201356.","journal-title":"Cancer"},{"issue":"16","key":"724_CR39","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1200\/JCO.2004.02.080","volume":"22","author":"H Ren","year":"2004","unstructured":"Ren H, Tang X, Lee JJ, Feng L, Everett AD, Hong WK, Khuri FR, Mao L. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2004;22(16):3230\u20137.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"6","key":"724_CR40","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1158\/1535-7163.MCT-12-0832","volume":"12","author":"HE Tsai","year":"2013","unstructured":"Tsai HE, Liu GS, Kung ML, Liu LF, Wu JC, Tang CH, Huang CH, Chen SC, Lam HC, Wu CS, et al. Downregulation of hepatoma-derived growth factor contributes to retarded lung metastasis via inhibition of epithelial-mesenchymal transition by systemic POMC gene delivery in melanoma. Mol Cancer Ther. 2013;12(6):1016\u201325.","journal-title":"Mol Cancer Ther"},{"issue":"16","key":"724_CR41","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.2217\/fon.14.194","volume":"10","author":"C Bao","year":"2014","unstructured":"Bao C, Wang J, Ma W, Wang X, Cheng Y. HDGF: a novel jack-of-all-trades in cancer. Fut Oncol. 2014;10(16):2675\u201385.","journal-title":"Fut Oncol"},{"issue":"11","key":"724_CR42","doi-asserted-by":"publisher","first-page":"483.e481","DOI":"10.1016\/j.urolonc.2016.05.027","volume":"34","author":"A Shetty","year":"2016","unstructured":"Shetty A, Dasari S, Banerjee S, Gheewala T, Zheng G, Chen A, Kajdacsy-Balla A, Bosland MC, Munirathinam G. Hepatoma-derived growth factor: a survival-related protein in prostate oncogenesis and a potential target for vitamin K2. Urol Oncol. 2016;34(11):483.e481-483.e488.","journal-title":"Urol Oncol"},{"issue":"3","key":"724_CR43","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s12079-022-00717-8","volume":"17","author":"Y Guo","year":"2023","unstructured":"Guo Y, Xu H, Huang M, Ruan Y. BLM promotes malignancy in PCa by inducing KRAS expression and RhoA suppression via its interaction with HDGF and activation of MAPK\/ERK pathway. J Cell Commun Signal. 2023;17(3):757\u201372.","journal-title":"J Cell Commun Signal"},{"issue":"9","key":"724_CR44","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/hmg\/dds006","volume":"21","author":"ST Chelbi","year":"2012","unstructured":"Chelbi ST, Wilson ML, Veillard AC, Ingles SA, Zhang J, Mondon F, Gascoin-Lachambre G, Doridot L, Mignot TM, Rebourcet R, et al. Genetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseases. Hum Mol Genet. 2012;21(9):1968\u201378.","journal-title":"Hum Mol Genet"},{"issue":"9","key":"724_CR45","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.150071","volume":"5","author":"A P\u00e9r\u00e9-Brissaud","year":"2015","unstructured":"P\u00e9r\u00e9-Brissaud A, Blanchet X, Delourme D, P\u00e9lissier P, Forestier L, Delavaud A, Duprat N, Picard B, Maftah A, Br\u00e9maud L. Expression of SERPINA3s in cattle: focus on bovSERPINA3-7 reveals specific involvement in skeletal muscle. Open Biol. 2015;5(9): 150071.","journal-title":"Open Biol"},{"issue":"6712","key":"724_CR46","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/25387","volume":"396","author":"RM Pitti","year":"1998","unstructured":"Pitti RM, Marsters SA, Lawrence DA, Roy M, Kischkel FC, Dowd P, Huang A, Donahue CJ, Sherwood SW, Baldwin DT, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature. 1998;396(6712):699\u2013703.","journal-title":"Nature"},{"issue":"5","key":"724_CR47","first-page":"4370","volume":"15","author":"T Zhao","year":"2018","unstructured":"Zhao T, Xu Y, Ren S, Liang C, Zhou X, Wu J. The siRNA silencing of DcR3 expression induces Fas ligand-mediated apoptosis in HepG2 cells. Exp Ther Med. 2018;15(5):4370\u20138.","journal-title":"Exp Ther Med"},{"issue":"4","key":"724_CR48","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.21037\/jgo-21-303","volume":"12","author":"C Zhang","year":"2021","unstructured":"Zhang C, Li H, Huang Y, Tang Y, Wang J, Cheng Y, Wei Y, Zhu D, Cao Z, Zhou J. Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. J Gastroint Oncol. 2021;12(4):1673\u201390.","journal-title":"J Gastroint Oncol"},{"issue":"9","key":"724_CR49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.prp.2010.05.011","volume":"206","author":"G Chen","year":"2010","unstructured":"Chen G, Rong M, Luo D. TNFRSF6B neutralization antibody inhibits proliferation and induces apoptosis in hepatocellular carcinoma cell. Pathol Res Pract. 2010;206(9):631\u201341.","journal-title":"Pathol Res Pract"},{"issue":"35","key":"724_CR50","doi-asserted-by":"publisher","first-page":"9810","DOI":"10.1073\/pnas.1606862113","volume":"113","author":"Y Wang","year":"2016","unstructured":"Wang Y, Begley M, Li Q, Huang HT, Lako A, Eck MJ, Gray NS, Mitchison TJ, Cantley LC, Zhao JJ. Mitotic MELK-eIF4B signaling controls protein synthesis and tumor cell survival. Proc Natl Acad Sci USA. 2016;113(35):9810\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"13","key":"724_CR51","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1002\/pros.22693","volume":"73","author":"K Ren","year":"2013","unstructured":"Ren K, Gou X, Xiao M, Wang M, Liu C, Tang Z, He W. The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B. Prostate. 2013;73(13):1462\u20139.","journal-title":"Prostate"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-025-00724-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-025-00724-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T13:05:34Z","timestamp":1740402334000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-025-00724-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["724"],"URL":"https:\/\/doi.org\/10.1186\/s40246-025-00724-x","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"29 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}